| Medical and Health Sciences | Lifetime | 47 | US 25 | 100.00 |
| Economics and Finance | Lifetime | 112 | US 77 | 99.89 |
| Medical and Health Sciences | 2021-2025 | 497 | US 172 | 99.89 |
| Economics and Finance | 2021-2025 | 201 | US 23 | 99.38 |
| Oncology | Lifetime | 10 | US 7 | 99.98 |
| Econometrics and Quantitative Economics | Lifetime | 56 | US 36 | 99.91 |
| Pediatrics, Perinatology and Child Health | Lifetime | 41 | US 22 | 99.87 |
| General Health Professions | Lifetime | 160 | US 81 | 99.80 |
| Pulmonary and Respiratory Medicine | Lifetime | 110 | US 59 | 99.86 |
| Sociology and Political Science | Lifetime | 888 | US 499 | 99.64 |
| Public, Environmental and Occupational Health | Lifetime | 463 | US 231 | 99.34 |
| Management Science and Operations Research | Lifetime | 630 | US 258 | 97.52 |
| Hematology | Lifetime | 373 | US 185 | 97.77 |
| Pathology and Forensic Medicine | Lifetime | 657 | US 302 | 97.04 |
| Psychiatry and Mental health | Lifetime | 675 | US 330 | 97.39 |
| Rheumatology | Lifetime | 743 | US 338 | 96.19 |
| Health | Lifetime | 824 | US 437 | 93.33 |
| Obstetrics and Gynecology | Lifetime | 643 | US 281 | 92.85 |
| Reproductive Medicine | Lifetime | 744 | US 360 | 91.99 |
| Otolaryngology | Lifetime | 447 | US 220 | 91.32 |
| Dermatology | Lifetime | 819 | US 334 | 90.33 |
| Medical Genetics | Lifetime | 974 | US 489 | 86.70 |
| Econometrics and Quantitative Economics | 2021-2025 | 164 | US 10 | 99.38 |
| Oncology | 2021-2025 | 136 | US 58 | 99.05 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 190 | US 62 | 98.58 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 154 | US 54 | 97.54 |
| Public, Environmental and Occupational Health | 2021-2025 | 440 | US 167 | 95.93 |
| Clinical Psychology | 2021-2025 | 582 | US 228 | 94.25 |
| Epidemiology | 2021-2025 | 911 | US 329 | 90.75 |
| Hematology | 2021-2025 | 254 | US 118 | 89.71 |
| Rheumatology | 2021-2025 | 320 | US 103 | 88.60 |
| Immunology | 2021-2025 | 516 | US 187 | 85.29 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 1 | US 1 | 99.98 |
| Cancer survivorship and care | Lifetime | 1 | US 1 | 99.99 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 6 | US 2 | 99.97 |
| Family Support in Illness | Lifetime | 2 | US 2 | 99.90 |
| Economic and Financial Impacts of Cancer | Lifetime | 2 | US 2 | 99.97 |
| Palliative Care and End-of-Life Issues | Lifetime | 6 | US 3 | 99.88 |
| Cancer-related cognitive impairment studies | Lifetime | 3 | US 3 | 99.71 |
| Health and Wellbeing Research | Lifetime | 7 | US 4 | 99.72 |
| Cancer Treatment and Pharmacology | Lifetime | 26 | US 16 | 99.88 |
| Multiple and Secondary Primary Cancers | Lifetime | 14 | US 5 | 99.72 |
| Renal cell carcinoma treatment | Lifetime | 36 | US 28 | 99.74 |
| Delphi Technique in Research | Lifetime | 10 | US 1 | 99.63 |
| Erythropoietin and Anemia Treatment | Lifetime | 18 | US 9 | 99.46 |
| Chronic Disease Management Strategies | Lifetime | 60 | US 26 | 99.29 |
| Management of metastatic bone disease | Lifetime | 44 | US 25 | 98.93 |
| Patient Satisfaction in Healthcare | Lifetime | 47 | US 31 | 99.20 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 64 | US 30 | 99.16 |
| Lung Cancer Treatments and Mutations | Lifetime | 405 | US 205 | 99.05 |
| Cancer Diagnosis and Treatment | Lifetime | 252 | US 134 | 98.52 |
| Oral health in cancer treatment | Lifetime | 50 | US 28 | 98.49 |
| Resilience and Mental Health | Lifetime | 138 | US 90 | 98.41 |
| Head and Neck Cancer Studies | Lifetime | 327 | US 162 | 98.64 |
| Optimism, Hope, and Well-being | Lifetime | 65 | US 53 | 98.13 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 307 | US 148 | 98.41 |
| Global Cancer Incidence and Screening | Lifetime | 346 | US 187 | 98.25 |
| Ovarian cancer diagnosis and treatment | Lifetime | 439 | US 215 | 98.17 |
| Nutrition and Health in Aging | Lifetime | 688 | US 249 | 97.67 |
| Patient-Provider Communication in Healthcare | Lifetime | 247 | US 111 | 97.26 |
| Lung Cancer Research Studies | Lifetime | 642 | US 275 | 97.81 |
| Meta-analysis and systematic reviews | Lifetime | 175 | US 47 | 97.20 |
| Renal and related cancers | Lifetime | 592 | US 301 | 97.35 |
| Neuroendocrine Tumor Research Advances | Lifetime | 818 | US 315 | 97.50 |
| Clinical practice guidelines implementation | Lifetime | 389 | US 108 | 95.90 |
| Health, psychology, and well-being | Lifetime | 312 | US 100 | 96.16 |
| BRCA gene mutations in cancer | Lifetime | 973 | US 507 | 94.67 |
| Psychometric Methodologies and Testing | Lifetime | 136 | US 91 | 93.43 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 758 | US 285 | 92.31 |
| Advances in Oncology and Radiotherapy | Lifetime | 657 | US 320 | 90.22 |
| Medication Adherence and Compliance | Lifetime | 880 | US 438 | 90.52 |
| Reliability and Agreement in Measurement | Lifetime | 883 | US 327 | 52.75 |
| Cancer survivorship and care | 2021-2025 | 1 | US 1 | 99.76 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 25 | US 8 | 99.43 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 16 | US 10 | 99.26 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 13 | US 9 | 99.29 |
| Clinical practice guidelines implementation | 2021-2025 | 21 | US 4 | 97.08 |
| Chronic Disease Management Strategies | 2021-2025 | 76 | US 14 | 97.05 |
| Renal cell carcinoma treatment | 2021-2025 | 134 | US 56 | 97.56 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 273 | US 111 | 95.63 |
| Cancer-related cognitive impairment studies | 2021-2025 | 62 | US 32 | 93.71 |
| Infant Development and Preterm Care | 2021-2025 | 281 | US 75 | 93.07 |
| Diabetes Management and Education | 2021-2025 | 158 | US 58 | 92.31 |
| Cancer Treatment and Pharmacology | 2021-2025 | 362 | US 130 | 92.62 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 164 | US 66 | 87.49 |
| Meta-analysis and systematic reviews | 2021-2025 | 179 | US 27 | 90.54 |
| Global Cancer Incidence and Screening | 2021-2025 | 916 | US 400 | 88.22 |
| Neutropenia and Cancer Infections | 2021-2025 | 299 | US 111 | 83.35 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 477 | US 62 | 86.92 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 725 | US 130 | 86.21 |
| Delphi Technique in Research | 2021-2025 | 309 | US 34 | 81.73 |
| Patient-Provider Communication in Healthcare | 2021-2025 | 469 | US 182 | 82.45 |
| Complement system in diseases | 2021-2025 | 391 | US 99 | 82.73 |
| Blood groups and transfusion | 2021-2025 | 592 | US 167 | 80.36 |
| Family Support in Illness | 2021-2025 | 849 | US 269 | 76.74 |
| Advanced Causal Inference Techniques | 2021-2025 | 528 | US 285 | 68.89 |
| Psychometric Methodologies and Testing | 2021-2025 | 204 | US 93 | 56.43 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 836 | US 306 | 48.97 |